Strikes, Supply Challenges Strain Mexican Healthcare System

Health workers mobilized in Mexico City this week to demand better wages and more medical supplies, highlighting systemic challenges in the country’s healthcare sector. About 3,000 staff from 100 hospitals and 20 health jurisdictions, affiliated with IMSS-Bienestar and the State of Mexico’s Ministry of Health, participated in the protest.

The protest, called the “March for Labor Dignity,” addressed persistent shortages of medicines and medical supplies, budget cuts, workplace violence, and unfulfilled economic benefits. Leaders from the National Union of Health Ministry Workers (SNTSA) and IMSS-Bienestar emphasized the need for salary parity, permanent employment for contract workers, updated medical equipment, and sufficient staffing to ensure patient care across clinics, health centers, and hospitals in the State of Mexico. “Our goal is the full resolution of the demands submitted to the governor,” says Domingo Ortuño, Vice President, SNTSA, and Head, Section 9, reports La Prensa. 

The march underscores long-standing operational and structural challenges in Mexico’s health system. While IMSS reports a 97% supply rate for medicines and IMSS-Bienestar 92%, including 96% coverage for oncology drugs, watchdog groups continue to identify shortages in antibiotics, anesthetics, and other critical medications. Pharmaceutical industry representatives attribute delays in supply to historic government debts exceeding MX$40 billion (US$2.18 billion) and logistical bottlenecks at state-run distributor Birmex, where full warehouses have forced shipments to be returned. Patrick Devlyn, President, Health Commission at the Business Coordinating Council (CCE), says that delayed payments — sometimes up to 18 months beyond contract terms — strain suppliers’ operations and complicate timely delivery to hospitals.

Mexico’s medical device industry, a key export sector worth billions, also faces challenges. Tariffs on over 1,400 Asian-origin goods threaten access to essential Chinese raw materials for products including syringes, catheters, and diagnostic equipment. Carlos Salazar, President, National Association of Health Suppliers, says that cooperation with Chinese suppliers is crucial to sustaining production and global competitiveness. Government measures under Plan México aim to prioritize local manufacturing capacity while maintaining regulatory oversight from COFEPRIS.

On the policy and strategic front, Mexico and the Pan American Health Organization/World Health Organization (PAHO/WHO) recently presented the 2026–2031 Cooperation Strategy, focusing on primary care, prevention, and system strengthening. David Kershenobich, Minister of Health, says that the plan aligns with the government’s objective of building a “healthy republic,” while José Moya, PAHO/WHO representative, called it a framework for coordinated technical cooperation aimed at improving health outcomes. The strategy prioritizes reducing mortality from noncommunicable diseases, strengthening regulatory capacity, improving health security, and promoting regional self-sufficiency in science and innovation.

Despite these initiatives, OECD data illustrates persistent gaps in Mexico’s health system. Life expectancy stands at 75.5 years, 5.6 years below the OECD average, while preventable and treatable mortality rates are among the highest in the bloc. Suicide and daily smoking rates are below average, but alcohol consumption remains high and air pollution exceeds OECD norms. Access and quality indicators show that only 78% of the population is covered by a basic set of healthcare services, with 56% satisfied with care availability, below the OECD average of 64%. Childhood vaccination and breast cancer screening rates also lag behind international benchmarks.

Resource limitations contribute to these outcomes. Mexico spends US$1,588 per capita on health compared with the OECD average of US$5,967, and invests 3.6% of total health expenditure in prevention. Physician and nurse availability, hospital beds, and advanced imaging capacity remain constrained. The 2026 federal health budget will increase 6.4% to MX$2.45 trillion (US$136.1 billion), but analysts caution it may still fall short of population needs. Fiscal debates over earmarking taxes from sugary drinks and tobacco further complicate resource allocation.